Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer&#39;s disease: results of a multicenter, double-blind, randomized, placebo-controlled, clinical trial in three parallel groups.

Dimebon (latrepirdine) - BioXcel, BIGESPAS

http://www.ncbi.nlm.nih.gov/pubmed/42141012

Boris I Gorin; Dmitriy S Gorchakov; Elena A Tukhovskaya; Ksenia A Potapova; Stanislav O Pozdnyakov

May 18, 2026